Literature DB >> 22818728

Food products made with glycomacropeptide, a low-phenylalanine whey protein, provide a new alternative to amino Acid-based medical foods for nutrition management of phenylketonuria.

Sandra C van Calcar1, Denise M Ney.   

Abstract

Phenylketonuria (PKU), an inborn error in phenylalanine metabolism, requires lifelong nutrition management with a low-phenylalanine diet, which includes a phenylalanine-free amino acid-based medical formula to provide the majority of an individual's protein needs. Compliance with this diet is often difficult for older children, adolescents, and adults with PKU. The whey protein glycomacropeptide (GMP) is ideally suited for the PKU diet because it is naturally low in phenylalanine. Nutritionally complete, acceptable medical foods and beverages can be made with GMP to increase the variety of protein sources for the PKU diet. As an intact protein, GMP improves protein use and increases satiety compared with amino acids. Thus, GMP provides a new, more physiologic source of low-phenylalanine dietary protein for people with PKU.
Copyright © 2012 Academy of Nutrition and Dietetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22818728      PMCID: PMC3402906          DOI: 10.1016/j.jand.2012.05.004

Source DB:  PubMed          Journal:  J Acad Nutr Diet        ISSN: 2212-2672            Impact factor:   4.910


  71 in total

1.  Phenylalanine requirement in children with classical PKU determined by indicator amino acid oxidation.

Authors:  Glenda Courtney-Martin; Rachelle Bross; Mahroukh Raffi; Joe T R Clarke; Ronald O Ball; Paul B Pencharz
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-12       Impact factor: 4.310

2.  Glycomacropeptide and alpha-lactalbumin supplementation of infant formula affects growth and nutritional status in infant rhesus monkeys.

Authors:  Shannon L Kelleher; Dereck Chatterton; Karin Nielsen; Bo Lönnerdal
Journal:  Am J Clin Nutr       Date:  2003-05       Impact factor: 7.045

3.  Persistent protective effect of heat-killed Escherichia coli producing "engineered," recombinant peanut proteins in a murine model of peanut allergy.

Authors:  Xiu-Min Li; Kamal Srivastava; Alexander Grishin; Chih-Kang Huang; Brian Schofield; Wesley Burks; Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2003-07       Impact factor: 10.793

4.  Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite.

Authors:  W L Hall; D J Millward; S J Long; L M Morgan
Journal:  Br J Nutr       Date:  2003-02       Impact factor: 3.718

5.  Cognitive and behavioral development in maternal phenylketonuria offspring.

Authors:  Susan E Waisbren; Colleen Azen
Journal:  Pediatrics       Date:  2003-12       Impact factor: 7.124

6.  Role of nutrition in pregnancy with phenylketonuria and birth defects.

Authors:  Kimberlee Michals Matalon; Phyllis B Acosta; Colleen Azen
Journal:  Pediatrics       Date:  2003-12       Impact factor: 7.124

7.  Dietary threonine reduces plasma phenylalanine levels in patients with hyperphenylalaninemia.

Authors:  P Sanjurjo; L Aldamiz; G Georgi; J Jelinek; J I Ruiz; G Boehm
Journal:  J Pediatr Gastroenterol Nutr       Date:  2003-01       Impact factor: 2.839

8.  Are tablets a practical source of protein substitute in phenylketonuria?

Authors:  A MacDonald; C Ferguson; G Rylance; A A M Morris; D Asplin; S K Hall; I W Booth
Journal:  Arch Dis Child       Date:  2003-04       Impact factor: 3.791

9.  Free use of fruits and vegetables in phenylketonuria.

Authors:  A MacDonald; G Rylance; P Davies; D Asplin; S K Hall; I W Booth
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.750

10.  Administration of protein substitute and quality of control in phenylketonuria: a randomized study.

Authors:  A MacDonald; G Rylance; P Davies; D Asplin; S K Hall; I W Booth
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.750

View more
  19 in total

Review 1.  Emerging trends in nutraceutical applications of whey protein and its derivatives.

Authors:  Seema Patel
Journal:  J Food Sci Technol       Date:  2015-06-09       Impact factor: 2.701

2.  Development of Metabolic Phenotype in Phenylketonuria: Evaluation of the Blaskovics Protein Loading Test at 5 Years of Age.

Authors:  P Burgard; E Mönch; J Zschocke; U Wendel; U Langenbeck
Journal:  JIMD Rep       Date:  2015-12-19

3.  Metabolomic Markers of Essential Fatty Acids, Carnitine, and Cholesterol Metabolism in Adults and Adolescents with Phenylketonuria.

Authors:  Bridget M Stroup; Nivedita Nair; Sangita G Murali; Katarzyna Broniowska; Fran Rohr; Harvey L Levy; Denise M Ney
Journal:  J Nutr       Date:  2018-02-01       Impact factor: 4.798

Review 4.  Genetic etiology and clinical challenges of phenylketonuria.

Authors:  Nasser A Elhawary; Imad A AlJahdali; Iman S Abumansour; Ezzeldin N Elhawary; Nagwa Gaboon; Mohammed Dandini; Abdulelah Madkhali; Wafaa Alosaimi; Abdulmajeed Alzahrani; Fawzia Aljohani; Ehab M Melibary; Osama A Kensara
Journal:  Hum Genomics       Date:  2022-07-19       Impact factor: 6.481

5.  Glycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short-chain fatty acids, and is anti-inflammatory in mice.

Authors:  Emily A Sawin; Travis J De Wolfe; Busra Aktas; Bridget M Stroup; Sangita G Murali; James L Steele; Denise M Ney
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-08-06       Impact factor: 4.052

Review 6.  Phenylketonuria: translating research into novel therapies.

Authors:  Gladys Ho; John Christodoulou
Journal:  Transl Pediatr       Date:  2014-04

Review 7.  Advances in the nutritional and pharmacological management of phenylketonuria.

Authors:  Denise M Ney; Robert D Blank; Karen E Hansen
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2014-01       Impact factor: 4.294

8.  Low bone strength is a manifestation of phenylketonuria in mice and is attenuated by a glycomacropeptide diet.

Authors:  Patrick Solverson; Sangita G Murali; Suzanne J Litscher; Robert D Blank; Denise M Ney
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

Review 9.  Recommendations for the nutrition management of phenylalanine hydroxylase deficiency.

Authors:  Rani H Singh; Fran Rohr; Dianne Frazier; Amy Cunningham; Shideh Mofidi; Beth Ogata; Patricia L Splett; Kathryn Moseley; Kathleen Huntington; Phyllis B Acosta; Jerry Vockley; Sandra C Van Calcar
Journal:  Genet Med       Date:  2014-01-02       Impact factor: 8.822

10.  Chemical and functional properties of glycomacropeptide (GMP) and its role in the detection of cheese whey adulteration in milk: a review.

Authors:  Rajan Sharma; Yudhishthir Singh Rajput; Bimlesh Mann
Journal:  Dairy Sci Technol       Date:  2013-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.